Normal hematopoiesis is maintained by activated bone marrow CD4+ T cells

被引:92
作者
Monteiro, JP
Benjamin, A
Costa, ES
Barcinski, MA
Bonomo, A
机构
[1] Inst Nacl Canc, Coordenacao Pesquisa, Div Expt Med, Rio De Janeiro, Brazil
[2] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Histol & Embryol, BR-21941 Rio De Janeiro, Brazil
[3] Univ Fed Rio de Janeiro, Inst Pediat & Puericultura Martagao Gesteira, BR-21941 Rio De Janeiro, Brazil
[4] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, Brazil
[5] Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Dept Imunol, BR-21941 Rio De Janeiro, Brazil
关键词
D O I
10.1182/blood-2004-07-2856
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
CD4(+) T cells produce hematopoietic-related cytokines and are essential for hematopoiesis stimulation during infection and hematologic recovery after bone marrow transplantation. However, it remains unclear if T cells are necessary to maintain normal hematopoiesis. We report here that, in T-cell-deficient mice, terminal differentiation of myeloid progenitors is defective, resulting in very low levels of granulocytes in the periphery. Hematopoiesis is restored after thymus graft or reconstitution with CD4(+) T cells but not CD8(+) T cells. Bone,marrow CD4(+) T cells have an activated phenotype and produce cytokines, apparently, in the absence of exogenous stimulation. Transgenic mice carrying T-cell receptor specific for an ovalbumin peptide presented in the context of a specific class II molecule (I-A(d)) (DO11.10 RAG(-/-)) show the same hematopoietic deficiency as athymic mice. Their bone marrow CD4+ T cells are not activated, suggesting that hematopoiesis maintenance requires the presence of cognate antigen in order to activate bone marrow T-helper cells. In fact, priming of transgenic mice with ovalbumin restores normal hematopoiesis. The data show that the current concept of "normal hematopoiesis" does not reflect a basal bone marrow activity, but it is an antigen-induced state maintained by constant activation of bone marrow CD4(+) T cells. (C) 2005 by The American Society of Hematology.
引用
收藏
页码:1484 / 1491
页数:8
相关论文
共 60 条
[21]   The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation [J].
Ho, VT ;
Soiffer, RJ .
BLOOD, 2001, 98 (12) :3192-3204
[22]  
HUSS R, 1994, TRANSPLANTATION, V58, P1366
[23]  
ILDSTAD ST, 1986, J IMMUNOL, V136, P28
[24]  
KAUFMAN CL, 1994, BLOOD, V84, P2436
[25]   Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-free survival [J].
Keil, F ;
Prinz, E ;
Moser, K ;
Mannhalter, C ;
Kalhs, P ;
Worel, N ;
Rabitsch, W ;
Schulenburg, A ;
Mitterbauer, M ;
Greinix, H .
TRANSPLANTATION, 2003, 76 (01) :230-236
[26]   HETEROGENEITY IN LYMPHOKINE PROFILES OF CD4+ AND CD8+ T-CELLS AND CLONES ACTIVATED INVIVO AND INVITRO [J].
KELSO, A ;
TROUTT, AB ;
MARASKOVSKY, E ;
GOUGH, NM ;
MORRIS, L ;
PECH, MH ;
THOMSON, JA .
IMMUNOLOGICAL REVIEWS, 1991, 123 :85-114
[27]   Biology of hematopoietic stem cells and progenitors: Implications for clinical application [J].
Kondo, M ;
Wagers, AJ ;
Manz, MG ;
Prohaska, SS ;
Scherer, DC ;
Beilhack, GE ;
Shizuru, JA ;
Weissman, IL .
ANNUAL REVIEW OF IMMUNOLOGY, 2003, 21 :759-806
[28]   Dendritic cells signal T cells in the absence of exogenous antigen [J].
Kondo, T ;
Cortese, I ;
Markovic-Plese, S ;
Wandinger, KP ;
Carter, C ;
Brown, M ;
Leitman, S ;
Martin, R .
NATURE IMMUNOLOGY, 2001, 2 (10) :932-938
[29]   Failure of sustained engraftment after non-myeloablative conditioning with low-dose TBI and T cell-reduced allogeneic peripheral stem cell transplantation [J].
Kreiter, S ;
Winkelmann, N ;
Schneider, PM ;
Schuler, M ;
Fischer, T ;
Ullmann, AJ ;
Huber, C ;
Derigs, HG ;
Kolbe, K .
BONE MARROW TRANSPLANTATION, 2001, 28 (02) :157-161
[30]  
Lai YH, 1996, J IMMUNOL, V156, P3166